Benzodiazepine receptor ligands.: 8:: Synthesis and pharmacological evaluation of new pyrazolo[5,1-c] [1,2,4]benzotriazine 5-oxide 3-and 8-disubstituted:: High affinity ligands endowed with inverse-agonist pharmacological efficacy

被引:32
作者
Guerrini, G
Costanzo, A
Ciciani, G
Bruni, F
Selleri, S
Costagli, C
Besnard, F
Costa, B
Martini, C
De Siena, G
Malmberg-Aiello, P
机构
[1] Univ Florence, Dipartimento Sci Farmaceut, I-50019 Florence, Italy
[2] Sanofi Synthelabo, Dept Mol & Funct Genom, F-92500 Rueil Malmaison, France
[3] Univ Pisa, Dipartimento Psichiatria Neurobiol Farmacol & Bio, I-56126 Pisa, Italy
[4] Univ Florence, Dipartimento Farmacol Preclin & Clin Aiazzi Manc, I-50139 Florence, Italy
关键词
GABA(A)/BzR complex ligands; pyrazolo[5,1-c][1,2,4]benzotriazines; inverse-agonists; tricyclic heteroaromatic system;
D O I
10.1016/j.bmc.2005.08.058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The synthesis and the binding study of new 3-arylesters and 3-heteroarylpyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide 8-substituted are reported. The nature of these substituents (in terms of lipophilic and electronic features) seems to influence the binding affinity. High-affinity ligands were studied in mice in vivo for their pharmacological effects, considering six potential benzodiazepine actions: anxiolytic-like effects, muscle relaxant effects, motor coordination, anticonvulsant action, spontaneous motor activity, and ethanol-potentiating action. Compounds 4d and 6d showed an inverse-agonist profile. These compounds were evaluated also for their binding at benzodiazepine site on GABA(A) receptor complex (GABA(A)/BzR complex) subtype to evaluate their subtype selectivity. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:758 / 775
页数:18
相关论文
共 43 条
[41]   Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABAAα5 benzodiazepine binding site [J].
Street, LJ ;
Sternfeld, F ;
Jelley, RA ;
Reeve, AJ ;
Carling, RW ;
Moore, KW ;
McKernan, RM ;
Sohal, B ;
Cook, S ;
Pike, A ;
Dawson, GR ;
Bromidge, FA ;
Wafford, KA ;
Seabrook, GR ;
Thompson, SA ;
Marshall, G ;
Pillai, GV ;
Castro, JL ;
Atack, JR ;
MacLeod, AM .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (14) :3642-3657
[42]  
Tallarida RJ, 1984, MANUAL PHARM CALCULA
[43]  
XIAOHUI H, 2000, DRUG DES DISCOV, V17, P131